Skip to content

Vivani Medical VANI Lessee Operating Lease Liability Undiscounted Excess Amount

Lessee Operating Lease Liability Undiscounted Excess Amount at other companies

Prime Medicine logo
Prime MedicinePRME

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's lessee operating lease liability undiscounted excess amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's lessee operating lease liability undiscounted excess amount?
Vivani Medical (VANI) reported lessee operating lease liability undiscounted excess amount of $6.5M in Q1 2026.
How has Vivani Medical's lessee operating lease liability undiscounted excess amount changed year-over-year?
Vivani Medical's lessee operating lease liability undiscounted excess amount decreased by 18.6% year-over-year, from $7.99M to $6.5M.